Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
Rosemarie Davidson(The Netherlands Cancer Institute), Karol Axcrona(Norwegian Cancer Society), Jackie Cook(Sheffield Children's Hospital), Kate Richardson(The University of Texas Health Science Center at Houston), Hans F. A. Vasen(Leiden University Medical Center), Talia Boshari(McGill University Health Centre), Christos Mikropoulos(Institute of Cancer Research), Christina G. Selkirk(NorthShore University HealthSystem), Tokhir Dadaev(Institute of Cancer Research), Gerald W. Verhaegh(Radboud University Nijmegen), Derek J. Rosario(Royal Hallamshire Hospital), William D. Foulkes(McGill University Health Centre), Louise Taylor(Royal Marsden NHS Foundation Trust), Palle Jørn Sloth Osther(University of Southern Denmark), Thomas D. Jensen(Vejle Sygehus), Alexander Dias(Institute of Cancer Research), Emily Vertosick(Memorial Sloan Kettering Cancer Center), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Margreet G.E.M. Ausems(McGill University Health Centre), Janneke Ringelberg(Hereditary Disease Foundation), Christi J. van Asperen(Loyola University Medical Center), Jacquelyn Powers(University of Pennsylvania), Lambertus A. Kiemeney(Radboud University Nijmegen), Manuel R. Teixeira(Instituto Português de Oncologia Francisco Gentil), Jimmy Lam(Flinders Medical Centre), Wayne Glover(Duke Medical Center), Susan M. Domchek(University City Science Center), Dominika Wokołorczyk(International Hereditary Cancer Center), Saundra S. Buys(University of Utah), Lídia Feliubadaló(University of Cologne), Sibel Saya(Institute of Cancer Research), Lovise Mæhle(Unknown), Cezary Cybulski(International Hereditary Cancer Center), D. Gareth Evans(Manchester Academic Health Science Centre), Sofia Maia(Instituto Português de Oncologia Francisco Gentil), Wendy A. van Zelst-Stams(Radboud University Nijmegen), Rachel Hart(Birmingham Women's Hospital), Rogier A. Oldenburg(Erasmus MC), Jan C. Oosterwijk(University Medical Center Groningen), Charles B. Brendler(Johns Hopkins University), Elizabeth Page(Institute of Cancer Research), Tom Conner(University of Utah), Jeanette Rothwell(Manchester Academic Health Science Centre), R.G.H.M. Cremers(Radboud University Nijmegen), Rita K. Schmutzler(University of Cologne), Mónica Salinas(Institut d'Investigació Biomédica de Bellvitge), Kerstin Rhiem(University Hospital Cologne), Elizabeth Bancroft(Royal Marsden NHS Foundation Trust), Diana Eccles(Princess Anne Hospital)
Cited by 20
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k